Regulation of the immune system/hyperinflammation
-
•
Reduction of natural killer cell activity (Sugimoto et al., 1999; Yokoyama et al., 2000)
-
•
Reduction of inflammatory cytokines IL-1, IL-4, IL-6, IL-8, TNF-α (Liu et al., 2013; Yang et al., 2015; Chen et al., 2018)
-
•
Increase of antiinflammatory cytokine IL-10 and of CGRP (Liu et al., 2013; Yang et al., 2015; Chen et al., 2018)
|
Regulation of the endothelial dysfunction (Chen et al., 2012) |
Regulation of microcirculation and coagulopathy (Levy and Lorch, 1996; Hanamatsu et al., 2002; Pfister and Fischer, 2009; Yamazaki et al., 2012; Zhou et al., 2014; Punj, 2019) |
Reduction of (neurogenic) pulmonary edema (Pierach and Stotz, 1952; Zhang et al., 2013; Liu et al., 2017; Chen et al., 2018) |
Reduction of pulmonary arterial hypertension (Myers et al., 1998) |
Reduction of pathological positive feedback loops (Fischer, 2003; Jänig, 2011; Fischer, 2019) |